Targeted imaging of very late antigen-4 for noninvasive assessment of lung inflammation-fibrosis axis.

"Declarations Ethics approval and consent to participateAll methods were carried out in accordance with relevant guidelines and regulations. All experimental protocols were approved by the University of Pittsburgh IACUC and Radiation Safety Committees. The study was carried out in compliance with the ARRIVE guidelines. Consent for publicationNot applicable. Competing interestsThe authors have no relevant financial or non-financial interests to disclose. Competing interests The authors have no relevant financial or non-financial interests to disclose."

"Funding This study was supported by the National Heart, Lung, and Blood Institute (NHLBI) K08 HL144911 and Seed Fund from University of Pittsburgh to ST, NHLBI F30 HL158038 to PZM, and NHLBI R01 HL154629 to EMN and CJA. Hillman Cancer Center In Vivo Imaging Facility, a shared resource at the University of Pittsburgh, is supported by National Cancer Institute (NCI) P30CA047904."